argenx SE | ARGX - Pre Tax Profit

Stock Price
693.20
Daily Change
-1.00 -0.14%
Monthly
-2.45%
Yearly
37.43%
Q2 Forecast
656.38

argenx SE reported $403.29M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
AstraZeneca USD 3.91B 1.28B Mar/2026
Genmab DKK 55M 427M Dec/2025
GlaxoSmithKline GBP 2.14B 919M Mar/2026
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Lakefront Biotherapeutics EUR 13.96M 769.2M Mar/2026
Qiagen NV USD 109.17M 25.56M Dec/2025
UCB EUR 789M 427M Jun/2025